Lower FBP1 expression has been detected in multiple cancers, including hepatocellular, colon, gastric cancer, basal-like breast cancer (BLBC), clear cell renal cell carcinoma (ccRCC), and pancreatic cancer [10, 13–19], and correlated with advanced tumor stages and worse patient prognosis. Here, FBP1 is linked to clear cell renal carcinoma.